{"id":"NCT03192150","sponsor":"Sun Pharmaceutical Industries Limited","briefTitle":"2nd Study to Assess ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract Surgery","officialTitle":"A Phase 3, Randomized, Multicenter, Double-masked Study to Compare the Ocular Safety, Tolerability, and Efficacy of ISV-305 (0.1% Dexamethasone in DuraSite® 2) to DuraSite 2 Vehicle for the Treatment of Inflammation and Pain Associated With Cataract Surgery","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-01-03","primaryCompletion":"2019-11-18","completion":"2019-11-18","firstPosted":"2017-06-19","resultsPosted":"2021-01-11","lastUpdate":"2021-11-19"},"enrollment":246,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Inflammation and Pain Associated With Cataract Surgery"],"interventions":[{"type":"DRUG","name":"ISV-305","otherNames":[]},{"type":"OTHER","name":"Vehicle","otherNames":[]}],"arms":[{"label":"ISV-305","type":"EXPERIMENTAL"},{"label":"Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the ocular safety, tolerability, and efficacy of ISV-305 (Dexamethasone in DuraSite® 2) compared to Vehicle in the treatment of inflammation and pain associated with cataract surgery.","primaryOutcome":{"measure":"Number of Participants With Anterior Chamber Cell Grade 0 in Study Eye at Day 15 (Last Observation Carried Forward) in the Modified Intent to Treat (mITT) Population","timeFrame":"Day 15","effectByArm":[{"arm":"ISV-305","deltaMin":92,"sd":null},{"arm":"Vehicle","deltaMin":16,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.0001"}]},"eligibility":{"minAge":"17 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":12},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":152},"commonTop":["Anterior chamber cell","Conjunctival hyperaemia","Visual acuity reduced","Corneal oedema","Anterior chamber flare"]}}